The U.S. FDA has approved Lyumjev, Lilly’s new rapid-acting insulin indicated to improve glycemic control in adults with…
Insulin
Will Weekly Basal Insulin be Game Changer?
Called “transformational” by its lead investigator, a new weekly basal insulin cleared a major hurdle by posting positiv…
Trump To Slash Insulin Costs for Medicare Patients
President Trump has announced that monthly co-pays for Medicare insulin will be capped at just $35, beginning in January…
The Case for Using Regular (R) Insulin
As a teen athlete with Type 1 diabetes, I achieve normal blood sugars using a few key tricks from Dr. Bernstein. One of …
Can COVID-19 Help Cut Insulin Prices Permanently?
As the new coronavirus pandemic continues to disrupt life across the country, there may be a unique opportunity to perma…
How to get Reduced Price Insulin during the COVID-19 Pandemic
Do you fear that you won’t be able to afford your insulin during COVID-19? The big three insulin manufacturers have assi…
The FDA Just Created a Path for ‘Generic’ Insulin
Last week the US FDA announced a potential milestone for people with diabetes: it just got a lot easier to get a generic…
New CMS Model will Reduce Insulin Costs to $35 for Medicare Part D Beneficiaries
The Centers for Medicare and Medicaid Services (CMS) has announced it will allow Medicare Part D prescription drug plans…
Fiasp Faster-Acting Insulin Approved for Children with Diabetes
Two years after the approval of Fiasp faster-acting insulin in adults, Novo Nordisk has announced the FDA approval of Fi…
T1International’s Report on Insulin Prices Around the World
In a time when the insulin price crisis in America has become a such prominent news story, it’s easy to lose sight of th…
